[Rectourethral fistula treatment using the modified York Mason technique: Failure factors assessment].

Cure de fistule recto-urétrale par la technique modifiée de York Mason : évaluation des facteurs d’échec.

Journal

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie
ISSN: 1166-7087
Titre abrégé: Prog Urol
Pays: France
ID NLM: 9307844

Informations de publication

Date de publication:
Feb 2022
Historique:
received: 14 04 2021
revised: 31 05 2021
accepted: 18 06 2021
pubmed: 11 8 2021
medline: 15 2 2022
entrez: 10 8 2021
Statut: ppublish

Résumé

To assess surgical outcomes and failure factors in the management of rectourethral fistulas treated surgically with the modified York Mason technique based on our center's 25 years of experience. From 1997 to 2021, in a single center study, a total of 35 consecutive patients, underwent rectourethral fistula cure, using the modified York Mason technique. Preoperative patient data, surgical outcomes and failure factors were assessed. Of the 35 patients, 28 were successfully managed without the need of further intervention (80%). Median age was 67 years (IQR 62-72) and median follow-up time was 71 months (IQR 30-123). There was no significant difference between the patients that had recurrence or not after the first York Mason. The modified York Mason technique offers a high success rate for the cure of iatrogenic rectourethral fistulas. No predictive factor of failure, after a first cure of recto-uretral fistula by modified York-Mason technique was reported. 3.

Identifiants

pubmed: 34373197
pii: S1166-7087(21)00169-X
doi: 10.1016/j.purol.2021.06.005
pii:
doi:

Types de publication

Journal Article

Langues

fre

Sous-ensembles de citation

IM

Pagination

139-145

Informations de copyright

Copyright © 2021 Elsevier Masson SAS. All rights reserved.

Auteurs

C Lainé (C)

Service d'urologie, institut mutualiste Montsouris, 42, boulevard Jourdan, 75014 Paris, France.

F Rozet (F)

Service d'urologie, institut mutualiste Montsouris, 42, boulevard Jourdan, 75014 Paris, France. Electronic address: francois.rozet@imm.fr.

A Mombet (A)

Service d'urologie, institut mutualiste Montsouris, 42, boulevard Jourdan, 75014 Paris, France.

N Cathala (N)

Service d'urologie, institut mutualiste Montsouris, 42, boulevard Jourdan, 75014 Paris, France.

E Barret (E)

Service d'urologie, institut mutualiste Montsouris, 42, boulevard Jourdan, 75014 Paris, France.

R Sanchez Salas (R)

Service d'urologie, institut mutualiste Montsouris, 42, boulevard Jourdan, 75014 Paris, France.

P Macek (P)

Service d'urologie, institut mutualiste Montsouris, 42, boulevard Jourdan, 75014 Paris, France.

Y Barbe (Y)

Service d'urologie, institut mutualiste Montsouris, 42, boulevard Jourdan, 75014 Paris, France.

X Cathelineau (X)

Service d'urologie, institut mutualiste Montsouris, 42, boulevard Jourdan, 75014 Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH